The roles of T lymphocytes and natural killer cells in chronic infection of hepatitis B virus

doi:10.3969/j.issn.1673-8640.2014.01.002

Abstract

Abstract:

Chronic infection caused by hepatitis B virus (HBV) is a serious infectious disease to threaten health in our country. The immunological mechanism of the chronicity has been the focus. The paper summarizes the development of the roles of T lymphocytes and natural killer(NK) cells in chronic infection of HBV, in order to help with developing insights into the cellular immune in chronic infection of HBV and to provide a new thought to diagnose and treat the chronic infection of HBV.

Key words: T lymphocyte, Natural killer cell, Hepatitis B

CLC Number:

R446.63

LIANG Yan, WANG Hao, ZHONG Renqian.. The roles of T lymphocytes and natural killer cells in chronic infection of hepatitis B virus[J]. , 2014, 29(1): 4-9.

References

[1] 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 [J].中华肝脏病杂志, 2005, 13(12):881-891.
[2] Mohamed R, Desmond P, Suh DJ, et al. Practical difficulties in the management of hepatitis B in the Asia-Pacific region[J].J Gastroenterol Hepatol, 2004, 19(9): 958-969.
[3] 刘明, 沈韻, 陆颖, 等.慢性乙型肝炎病毒感染者外周血T细胞亚群变化与其血清HBV DNA的水平分析[J].中国实验诊断学, 2008, 12(2):232-235.
[4] Shimizu Y. T cell immunopathogenesis and immunotherapeutic strategies for chronic hepatitis B virus infection[J]. World J Gastroenterol, 2012, 18(20): 2443-2451.
[5] Reignat S, Webster GJ, Brown D, et al. Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection[J].J Exp Med, 2002, 195(9): 1089-1101.
[6] Chisari FV, Isogawa M, Wieland SF. Pathogenesis of hepatitis B virus infection[J]. Pathol Biol(Paris), 2010, 58(4): 258-266.
[7] Rehermann B. Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells[J]. Nat Med, 2013, 19(7): 859-868.
[8] Fisicaro P, Valdatta C, Massari M, et al. Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B [J].Gastroenterology, 2010, 138(2):682-693.
[9] Ju Y, Hou N, Zhang XN, et al. Blockade of Tim-3 pathway ameliorates interferon-gamma production from hepatic CD8⁺ T cells in a mouse model of hepatitis B virus infection[J].Cell Mol Immunol, 2009, 6(1): 35-43.
[10] Bouillet P, Metcalf D, Huang DC, et al. Proapopto-tic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity [J].Science, 1999, 286(5445):1735-1738.
[11] Schurich A, Khanna P, Lopes AR, et al. Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection[J]. Hepatology, 2011, 53(5):1494-1503.
[12] Stoop JN, Claassen MA, Woltman AM, et al. Intrehepatic regulatory T cells are phenotypically distinct from their peripheral counterparts in chronic HBV patients[J].Clin Immunol, 2008, 129(3): 419-427.
[13] Stoop JN, van der Molen RG, Baan CC, et al. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection[J]. Hepatology, 2005, 41(4): 771-778.
[14] Xu D, Fu J, Jin L, et al. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B[J].J Immunol, 2006, 177(1):739-747.
[15] 冯霞, 闫惠平, 廖慧钰, 等.慢性乙肝患者抗病毒治疗前后特异性T细胞免疫观察[J].中华微生物和免疫学杂志, 2011, 31(5):438-442.
[16] Frebel H, Richter K, Oxenius A. How chronic viral infections impact on antigen-specific T-cell responses[J]. Eur J Immunol, 2010, 40(3):654-663.
[17] Bertoletti A, Ferrari C. Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection[J].Gut, 2012, 61(12): 1754-1764.
[18] Zhang JY, Zhang Z, Lin F, et al.Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B[J].Hepatology, 2010, 51(1):81-91.
[19] Yang B, Wang Y, Zhao C, et al. Increased Th17 cells and interleukin-17 contribute to immune activation and disease aggravation in patients with chronic hepatitis B virus infection[J]. Immunol Lett, 2013, 149(1-2): 41-49.
[20] Sun HQ, Zhang JY, Zhang H, et al. Increased Th17 cells contribute to disease progression in patients with HBV-associated liver cirrhosis[J]. J Viral Hepat, 2012, 19(6): 396-403.
[21] Zhang JY, Zhang Z, Lin F, et al. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B[J]. Hepatology, 2010, 51(1): 81-91.
[22] Xia L, Tian D, Huang W, et al. Upregulation of IL-23 expression in patients with chronic hepatitis B is mediated by the HBx/ERK/NF-κB pathway[J]. J Immunol, 2012, 188(2): 753-764.
[23] Xing TJ, Xu HT, Yu WQ. Role of T follicular helper cells and their associated molecules in the pathogenesis of chronic hepatitis B virus infection[J]. Exp Ther Med, 2013, 5(3): 885-889.
[24] Jiang X, Zhang M, Lai Q, et al. Restored circulating invariant NKT cells are associated with viral control in patients with chronic hepatitis B[J]. PLoS One, 2011, 6(12): e28871.
[25] Ma J, Guo X, Wu X, et al. Association of NKG2D genetic polymorphism with susceptibility to chronic hepatitis B in a Han Chinese population[J]. J Med Virol, 2010, 82(9): 1501-1507.
[26] Huang M, Sun R, Wei H, et al. Simultaneous knockdown of multiple ligands of innate receptor NKG2D high efficiently prevents NK cell-mediated fulminant hepatitis in mice[J]. Hepatology, 2013, 57(1): 277-288.
[27] Micco L, Peppa D, Loggi E, et al. Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B[J]. J Hepatol, 2013, 58(2): 225-233.
[28] Sun C, Fu B, Gao Y, et al. TGF-β1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence[J]. PLoS Pathog, 2012, 8(3): e1002594.
[29] Paust S, Gill HS, Wang BZ, et al. Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses[J]. Nat Immunol, 2010, 11(12):1127-1135.
[30] Ichinohe T, Lee HK, Ogura Y, et al. Inflammasome recognition of influenza virus is essential for adaptive immune responses[J]. J Exp Med, 2009, 206(1):79-87.
[31] De Maria A, Bozzano F, Cantoni C, et al. Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid pro-ducers of abundant IFN-gamma on activation[J]. Proc Natl Acad Sci USA, 2011, 108(2):728-732.
[32] Zhang Z, Zhang S, Zou Z, et al. Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients[J]. Hepa-tology, 2011, 53(1):73-85.
[33] Burt BM, Plitas G, Zhao Z, et al. The lytic potential of human liver NK cells is restricted by their limited expression of inhibitory killer Ig-like receptors[J]. J Immunol, 2009, 183(3):1789-1796.
[34] Peppa D, Micco L, Javaid A, et al. Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection[J]. PLos Pathog, 2010, 6(12): e1001227.
[35] Peppa D, Gill US, Reynolds G, et al. Up-regulation of a death receptor renders antiviral T cells suscep-tible to NK cell-mediated deletion[J]. J Exp Med, 2013, 210(1): 99-114.
[36] Shi CC, Tjwa ET, Biesta PJ, et al. Hepatitis B virus suppresses the functional interaction between natural killer cells and plasmacytoid dendritic cells[J]. J Viral Hepat, 2012, 19(2): e26-e33.
[37] Tjwa ET, van Oord GW, Hegmans JP, et al. Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B[J]. J Hepatol, 2011, 54(2): 209-218.
[38] Ju Y, Hou N, Meng J, et al. T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B[J].J Hepatol, 2010, 52(3): 322-329.
[39] Radaeva S, Sun R, Jaruga B, et al. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners[J]. Gastroenterology, 2006, 130(2): 435-452.
[40] Zenewicz LA, Yancopoulos GD, Valenzuela DM, et al. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation[J]. Immunity, 2007, 27(4): 647-659.
[41] Kamimura H, Yamagiwa S, Tsuchiya A, et al. Reduced NKG2D ligand expression in hepatocellular carcinoma correlates with early recurrence[J]. J Hepatol, 2012, 56(2): 381-388.